Financial Ratios

VAISHALI PHARMA LTD.

NSE : VAISHALIBSE : ISIN CODE : INE972X01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( )0 0
NSE158.90-2.95 (-1.82 %)
PREV CLOSE( ) 161.85
OPEN PRICE ( ) 160.40
BID PRICE (QTY) 158.90 (832)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 40062
TODAY'S LOW / HIGH( ) 157.10 162.65
52 WK LOW / HIGH ( )114.85 203.6
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)6.263.820.990.031.08
   CEPS(Rs)6.744.251.400.450.93
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)31.2624.9921.2620.2732.47
   Tax Rate(%)25.3529.7625.5158.5636.99
Margin Ratios
   Core EBITDA Margin(%)13.469.084.921.502.77
   EBIT Margin(%)15.9410.847.494.395.05
   Pre Tax Margin(%)12.707.562.610.131.51
   PAT Margin (%)9.485.311.950.050.95
   Cash Profit Margin (%)10.205.912.740.781.31
Performance Ratios
   ROA(%)8.244.811.380.051.08
   ROE(%)22.2616.504.780.153.40
   ROCE(%)21.9218.8710.336.899.80
   Asset Turnover(x)0.870.910.710.891.13
   Sales/Fixed Asset(x)19.4924.5019.1624.6938.19
   Working Capital/Sales(x)1.723.102.442.893.66
Efficiency Ratios
   Fixed Capital/Sales(x)0.050.040.050.040.03
   Receivable days293.72301.44386.08292.96228.47
   Inventory Days9.642.934.985.656.92
   Payable days154.80198.07253.76172.05124.69
Valuation Parameters
   PER(x)23.3017.3432.861288.3525.11
   PCE(x)21.6515.5723.3489.6329.19
   Price/Book(x)4.672.651.531.981.34
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)2.391.180.960.970.61
   EV/Core EBITDA(x)14.3510.2811.5519.0311.18
   EV/EBIT(x)15.0010.8512.7822.2011.97
   EV/CE(x)2.111.090.600.890.66
   M Cap / Sales2.210.920.640.700.38
Growth Ratio
   Net Sales Growth(%)-8.1241.00-10.50-19.9810.81
   Core EBITDA Growth(%)33.8294.6045.00-24.35-8.75
   EBIT Growth(%)35.11103.8952.92-30.54-9.62
   PAT Growth(%)64.12284.583091.33-95.41-10.54
   EPS Growth(%)64.12284.583091.33-97.13-10.54
Financial Stability Ratios
   Total Debt/Equity(x)0.410.790.780.780.80
   Current Ratio(x)2.271.471.371.511.48
   Quick Ratio(x)2.171.461.361.491.46
   Interest Cover(x)4.923.301.531.031.43
   Total Debt/Mcap(x)0.090.300.510.390.60

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.